Cardiogenic shock is a life-threatening condition in which the heart suddenly cannot pump enough blood to meet the body's needs. This condition is most often caused by a severe heart attack, but not everyone who has a heart attack goes into cardiogenic shock. Cardiogenic shock is rare, without prompt treatment, it is often fatal. With prompt treatment, about half of affected people survive. In most cases, the main pumping chamber (left ventricle) is damaged, usually due to heart attack and lack of oxygen in the heart. A lack of oxygen-rich blood flow to this area of ​​the heart can weaken the heart muscle and lead to cardiogenic shock. Rarely, cardiogenic shock can result from damage to the heart's right ventricle, which pumps blood to the lungs for oxygen. Without prompt treatment, cardiogenic shock can be fatal. Another serious complication is damage to the liver, kidneys, and other organs from permanent oxygen deprivation. The best way to prevent cardiogenic shock is to make lifestyle changes to keep your heart healthy and your blood pressure under control. Maintain a healthy weight; Obesity contributes to other risk factors for heart attack and cardiogenic shock, including high blood pressure, cardiovascular disease, and diabetes. Losing just 10 pounds can lower your blood pressure and improve your cholesterol levels. If you are having a heart attack, acting quickly can prevent cardiogenic shock. If you think you're having a heart attack, see an ambulance. Cardiogenic shock (CS) is a common cause of death and despite advances in therapy, management remains a challenge. CS is caused by severe impairment of myocardial function, resulting in reduced cardiac output, end-organ hypoperfusion, and hypoxia. Clinically, this manifests as hypotension refractory to volume resuscitation, with features of end-organ hypoperfusion requiring pharmacological or mechanical intervention. Acute myocardial infarction (MI) accounts for 81% of CS patients. Cardiogenic shock is a primary heart disease characterized by a state of low cardiac output with circulatory failure, resulting in end-organ hypoperfusion and tissue hypoxia. This activity provides an overview of the assessment and management of cardiogenic shock and describes the role of professional teams in improving care for patients with this condition. Cardiogenic shock is clinically and biochemically defined as a primary heart disease those results in tissue hypoperfusion. Clinical criteria included systolic blood pressure ≤90 mm Hg for 30 minutes or less, or systolic blood pressure ≤90 mm Hg and urine output ≤30 ml/hr. cool limbs. Hemodynamic criteria included decreased cardiac index (≤2.2 liters per minute per square meter of body surface area) and increased pulmonary capillary wedge pressure >15 mm Hg. Circulatory failure leading to end-organ hypoperfusion and tissue hypoxia. The most common cause of cardiogenic shock is acute myocardial infarction, but other disorders that impair the myocardium, heart valves, conduction system, or pericardium can also cause cardiogenic shock. Despite advances in reperfusion therapy and mechanical circulatory support, morbidity and mortality in patients with cardiogenic shock remain high. Myocardial ischemia causes disruption of both systolic and diastolic left ventricular function, resulting in severe reduction of myocardial contractility.